Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Rudolf A. Werner, Seval Beykan, Takahiro Higuchi, Katharina Lückerath, Alexander Weich, Michael Scheurlen, Christina Bluemel, Ken Herrmann, Andreas K. Buck, Michael Lassmann, Constantin Lapa, Heribert Hänscheid
Published Jun 1, 2016 · Vol. 7, No. 27 · pp. 41233-41241
Liza C. Villaruz, Helen Jones, Sanja Dacic, Shira Abberbock, Brenda F. Kurland, Laura P. Stabile, Jill M. Siegfried, Thomas P. Conrads, Neil R. Smith, Mark J. O'Connor, Andrew J. Pierce, Christopher J. Bakkenist
Published Jun 1, 2016 · Vol. 7, No. 36 · pp. 57714-57725
Chun Wang, Hie-Won Hann, Zhong Ye, Richard S. Hann, Shaogui Wan, Xishan Ye, Peter D. Block, Bingshan Li, Ronald E. Myers, Xiaowei Wang, Hee-Soon Juon, Jesse Civan, Mimi Chang, Ho S. Bae, Jinliang Xing, Hushan Yang
